Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | EVP & Chief Commercial Officer | June 01, 2026 | June 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.67 · Expires 2034-06-01 | Direct | 60,372 |
Reported balance
After 2026-06-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 60,372 · Balance 60,372 F1: This award consists of stock options granted pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan") and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, in each case subject to the Reporting Person's continued service through the applicable vesting dates. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 124,017 |
Reported balance
After 2026-06-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-01 · Grant · Acquired 31,909 · Balance 124,017 F2: Grant of restricted stock units ("RSUs") pursuant to the Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3: All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: This award consists of stock options granted pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan") and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, in each case subject to the Reporting Person's continued service through the applicable vesting dates.
F2: Grant of restricted stock units ("RSUs") pursuant to the Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F3: All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 3, 2026 20:58 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantRestricted Stock Units · Derivative | 31,909 | $0.00 | $0.00 |
DisclosureSEC source: 0001814943-26-000003 · wk-form4_1780520318.xml · derivative · entry 2 McBreen Michael J. · CIK 0001814943 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,017 Underlying: Common Stock · 31,909 shares Expires not disclosed F2 · derivative.exercise_price: Grant of restricted stock units ("RSUs") pursuant to the Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. F3 · derivative.expiration_date: All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:58 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 60,372 | $0.00 Strike: $15.67 | $0.00 |
DisclosureSEC source: 0001814943-26-000003 · wk-form4_1780520318.xml · derivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,372 Underlying: Common Stock · 60,372 shares Expires 2034-06-01 F1 · derivative.exercise_date: This award consists of stock options granted pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan") and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, in each case subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantRestricted Stock Units · Derivative | 92,108 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001814943-26-000001 · wk-form4_1773350281.xml · derivative · entry 3 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,108 Underlying: Common Stock · 92,108 shares Expires not disclosed F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 7,247 | $9.61 | $69,643.67 |
DisclosureSEC source: 0001814943-26-000001 · wk-form4_1773350281.xml · nonDerivative · entry 2 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,743 Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 21:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 2,354 | $9.55 | $22,480.70 |
DisclosureSEC source: 0001814943-26-000001 · wk-form4_1773350281.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,990 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon- Qualified Stock Option (right to buy) · Derivative | 39,132 | $0.00 Strike: $23.95 | $0.00 |
DisclosureSEC source: 0000917520-25-000026 · wk-form4_1741897659.xml · derivative · entry 4 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,132 Underlying: Non-Qualified Stock Option (right to buy) · 39,132 shares Expires 2033-03-11 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2025. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 18,480 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-25-000026 · wk-form4_1741897659.xml · nonDerivative · entry 3 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,344 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,587 | $23.95 | $38,008.65 |
DisclosureSEC source: 0000917520-25-000026 · wk-form4_1741897659.xml · nonDerivative · entry 2 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,864 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 446 | $23.95 | $10,681.70 |
DisclosureSEC source: 0000917520-25-000026 · wk-form4_1741897659.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,451 Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,056 | $22.61 | $23,876.16 |
DisclosureSEC source: 0000917520-25-000021 · wk-form4_1741725046.xml · nonDerivative · entry 2 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,897 Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,229 | $22.61 | $27,787.69 |
DisclosureSEC source: 0000917520-25-000021 · wk-form4_1741725046.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,953 Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:19 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 1,700 | $24.16 | $41,063.50 |
DisclosureSEC source: 0000917520-24-000110 · wk-form4_1733260741.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,182 Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 440 | $35.88 | $15,787.20 |
DisclosureSEC source: 0000917520-24-000035 · wk-form4_1710361740.xml · nonDerivative · entry 6 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,882 Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,572 | $35.88 | $56,403.36 |
DisclosureSEC source: 0000917520-24-000035 · wk-form4_1710361740.xml · nonDerivative · entry 5 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,322 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon- Qualified Stock Option (right to buy) · Derivative | 28,226 | $0.00 Strike: $36.22 | $0.00 |
DisclosureSEC source: 0000917520-24-000035 · wk-form4_1710361740.xml · derivative · entry 7 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,226 Underlying: Common Stock · 28,226 shares Expires 2032-03-11 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2024. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 8,283 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000035 · wk-form4_1710361740.xml · nonDerivative · entry 4 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,894 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 12,220 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000035 · wk-form4_1710361740.xml · nonDerivative · entry 3 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,611 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 3,430 | $36.22 | $124,234.60 |
DisclosureSEC source: 0000917520-24-000035 · wk-form4_1710361740.xml · nonDerivative · entry 2 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,391 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 492 | $36.22 | $17,820.24 |
DisclosureSEC source: 0000917520-24-000035 · wk-form4_1710361740.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,821 Read SEC document |
| March 10, 2024 Filed Mar 12, 2024 21:15 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,198 | $36.73 | $44,002.54 |
DisclosureSEC source: 0000917520-24-000028 · wk-form4_1710278138.xml · nonDerivative · entry 2 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,313 Read SEC document |
| March 10, 2024 Filed Mar 12, 2024 21:15 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,457 | $36.73 | $53,515.61 |
DisclosureSEC source: 0000917520-24-000028 · wk-form4_1710278138.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,511 Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:49 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,516 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000007 · wk-form4_1708638570.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,968 F1 · shares: On February 20, 2024, the Compensation Committee certified that the Company met or exceeded the average three-year annual organic revenue growth rate target for the performance period under the March 12, 2021 performance stock award. Accordingly, shares will vest on March 12, 2024, the third anniversary of the grant date. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 298 | $52.61 | $15,677.78 |
DisclosureSEC source: 0001209191-23-018416 · doc4.xml · nonDerivative · entry 9 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,452 Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 655 | $52.61 | $34,459.55 |
DisclosureSEC source: 0001209191-23-018416 · doc4.xml · nonDerivative · entry 8 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,750 Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 427 | $52.87 | $22,575.49 |
DisclosureSEC source: 0001209191-23-018416 · doc4.xml · nonDerivative · entry 7 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,405 Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 451 | $52.87 | $23,844.37 |
DisclosureSEC source: 0001209191-23-018416 · doc4.xml · nonDerivative · entry 6 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,832 Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 751 | $52.87 | $39,705.37 |
DisclosureSEC source: 0001209191-23-018416 · doc4.xml · nonDerivative · entry 5 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,283 Read SEC document |
| March 11, 2023 Filed Mar 14, 2023 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 491 | $52.87 | $25,959.17 |
DisclosureSEC source: 0001209191-23-018416 · doc4.xml · nonDerivative · entry 4 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,034 Read SEC document |
| March 11, 2023 Filed Mar 14, 2023 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 857 | $52.87 | $45,309.59 |
DisclosureSEC source: 0001209191-23-018416 · doc4.xml · nonDerivative · entry 3 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,525 Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock option (right to buy) · Derivative | 19,912 | $0.00 Strike: $52.87 | $0.00 |
DisclosureSEC source: 0001209191-23-018416 · doc4.xml · derivative · entry 10 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,912 Underlying: Common Stock · 19,912 shares Expires 2031-03-10 F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 8,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018416 · doc4.xml · nonDerivative · entry 2 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,382 Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 9,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018416 · doc4.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,254 Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 1,843 | $54.29 | $100,064.39 |
DisclosureSEC source: 0001209191-23-017194 · doc4.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,796 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $54.2931 to $54.3001. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:58 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 723 | $55.09 | $39,830.07 |
DisclosureSEC source: 0001209191-23-016360 · doc4.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,639 Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009724 · doc4.xml · nonDerivative · entry 4 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,362 F3 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009724 · doc4.xml · nonDerivative · entry 3 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,443 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,008 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009724 · doc4.xml · nonDerivative · entry 2 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,763 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009724 · doc4.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,755 F1 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 20:41 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 599 | $56.87 | $34,065.13 |
DisclosureSEC source: 0001209191-22-044204 · doc4.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,289 Read SEC document |
| March 13, 2022 Filed Mar 15, 2022 20:38 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,083 | $65.11 | $70,514.13 |
DisclosureSEC source: 0001209191-22-018838 · doc4.xml · nonDerivative · entry 9 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,888 Read SEC document |
| March 13, 2022 Filed Mar 15, 2022 20:38 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 651 | $65.11 | $42,386.61 |
DisclosureSEC source: 0001209191-22-018838 · doc4.xml · nonDerivative · entry 8 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,971 Read SEC document |
| March 13, 2022 Filed Mar 15, 2022 20:38 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 289 | $65.11 | $18,816.79 |
DisclosureSEC source: 0001209191-22-018838 · doc4.xml · nonDerivative · entry 7 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,622 Read SEC document |
| March 13, 2022 Filed Mar 15, 2022 20:38 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 174 | $65.11 | $11,329.14 |
DisclosureSEC source: 0001209191-22-018838 · doc4.xml · nonDerivative · entry 6 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,911 Read SEC document |
| March 12, 2022 Filed Mar 15, 2022 20:38 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 679 | $65.11 | $44,209.69 |
DisclosureSEC source: 0001209191-22-018838 · doc4.xml · nonDerivative · entry 5 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,085 Read SEC document |
| March 12, 2022 Filed Mar 15, 2022 20:38 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,133 | $65.11 | $73,769.63 |
DisclosureSEC source: 0001209191-22-018838 · doc4.xml · nonDerivative · entry 4 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,764 Read SEC document |
| March 12, 2022 Filed Mar 15, 2022 20:38 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 376 | $65.11 | $24,481.36 |
DisclosureSEC source: 0001209191-22-018838 · doc4.xml · nonDerivative · entry 3 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,897 Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 20:38 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 9,371 | $0.00 Strike: $65.11 | $0.00 |
DisclosureSEC source: 0001209191-22-018838 · doc4.xml · derivative · entry 10 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,371 Underlying: Common Stock · 9,371 shares Expires 2030-03-11 F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2022. F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2022. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 20:38 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 7,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018838 · doc4.xml · nonDerivative · entry 2 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,273 Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 20:38 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018838 · doc4.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,593 Read SEC document |
| March 02, 2022 Filed Mar 9, 2022 21:06 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 466 | $67.59 | $31,496.94 |
DisclosureSEC source: 0001209191-22-017559 · doc4.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,261 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.